Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000126842 | SCV000170371 | benign | not specified | 2014-02-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000967366 | SCV001114747 | benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001197773 | SCV001368552 | benign | Combined oxidative phosphorylation defect type 15 | 2018-11-08 | criteria provided, single submitter | clinical testing | This variant was classified as: Benign. The following ACMG criteria were applied in classifying this variant: BS1,BS2. |
Ce |
RCV000967366 | SCV004132679 | benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | MTFMT: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000967366 | SCV005292483 | benign | not provided | criteria provided, single submitter | not provided |